Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice – results from the ElderTac study
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Brueckl, Wolfgang M.
Achenbach, H. Jost
Ficker, Joachim H.
Funding for this research was provided by:
Roche Pharma AG (Not applicable)